Skip to main content

Table 1 Reported cases of pure secretory carcinoma in situ

From: Pure secretory carcinoma in situ: a case report and literature review

Author

Sex

Age (yo)

Symptoms/ Duration (month)

Site/Location

Histological growth pattern

Treatment

HR

HER2

ETV6-NTRK3

Axillary status

Follow-up(m)

Kameyama et al [9]

M

51

Lump/ND

L/Subareolar

Papillary, cribriform

RM

ER+

ND

ND

-(0/?)

NED

Sato et al [10]

F

30

Lump/6

L/Lower inner

Papillary, cribriform

SM + SLNB

ER+,PR-

NE

-(0/2)(SLNB)

NED 60

Strauss et al [11]

F

73

ND

ND

ND

ND

ND

ND

ND

ND

ND

F

51

ND

ND

ND

ND

ND

ND

ND

ND

ND

F

46

ND

ND

ND

ND

ND

ND

ND

ND

ND

Our case

F

38

Bloody nipple discharge/1

L

Microcystic, solid,papillary

RM + SLNB

ER-,PR-

+

-(0/5)(SLNB)

NED 13

  1. Abbreviations: ER, estrogen receptor; F, female; HER2, human epidermal growth factor receptor 2; HR, hormone receptor; L, left breast; M, male; ND, not defined; NE, not examined; NED, not evidence of disease; PR, progesterone receptor; RM, radical mastectomy; SLNB, sentinel lymph node biopsy; SM, simple mastectomy;